5UEKI Y, YAMASAKI S, KANAMOTO Y, et al. Evaluation of filtration leukocytapheresis for use in the treatment of patients with rheumatoid arthritis[ J ]. Rheumatology(Oxford) , 2000, 39 ( 2 ) : 165 - 171.
6KEMPE K, TSUDA H, YANG K, et al. Filtration leukoeytapheresis therapy in the treatment of rheumatoid arthritis patients resistant to or failed with methotrexate[J]. Ther Apher Dial, 2004, 8(3) : 197 -205.
7YAMASAKI S, UEKI Y, NAKAMURA K, et al. Effect of filtration leukocytapheresis therapy: modulationof white blood cell enzyme activities in patients with rheumatoid arthritis [ J 1. Artificial Organs, 2002, 26(4): 378-384.
8UEKI Y, NAKAMURA H, KANAMOTO Y, et al. Comparison of lymphocyte depletion and clinical effectiveness on filtration leukocytapheresis in patients with rheumatoid arthritis[ J]. Ther Apher, 2001, 5(6) : 455 -461.
9LZUMI Y, TOMINAGA M, IWANAGA N, et al. Twenty - four -week follow - up examination of a leukoeytapheresis therapy in rheumatoid arthritis[ J ]. Mod Rheumatol, 2006, 16 ( 1 ) : 20 - 23.
10EGUCHI K, SAITO K, KONDO M, et al. Enhanced effect of high - dose leukocytapheresis using a large filter in rheumatoid arthritis[J]. Mod Rheumatol, 2007, 17 (6) : 481 - 485.
3[1]DJ Wallace. Apheresis for lupus erthematosus. Lupus, (1999)8:174- 180
4[2]Csipo I, Kiss E, soltesz P, et al. Effect of plasmapheresis on ligand binding capacity and expression of erythrocyte complement receptor type Ⅰ (CR Ⅰ )of patient with systemic lupus erythematosus. Clin Exp Immunol, 1999,118(3) :458 - 464
5[3]Jones JV. Response to apheresis:problems of assessment in immune disease. Clin Nephrol, 1986,26 (Suppl 1 ) :70 - 75
6[4]Csipo l,kavai M, kiss E, et al. Serum complememt activation of SLE patients during plasmapheresis. Autoimmunity, 1997, 25 ( 3 ):139 - 146
7[5]Funauchi M, lkoma S, Enomoto H, et al. High affinity anti DNA antibody parallels clinical course of immunoadsorption therapy for systemic lupus erythematosus. Intern Med, 1996,35(5) :367 - 372
8[6]Schiel R, Bambauer R, Lataza R, et al. Cycloporin and plasmapheresis in treatment of progressivae systemic lupus erythematosus.Transfus Sci, 1997, 18( 1 ) :91 - 97
9[7]Sharon Z, Roberts JL, Fennel JS, et al. Plasmapheresis in lupus nephritis. Plasma Ther, 1982,3:165 - 169
10[8]Lewis EJ, Hunsicker LG, Lan SP, et al. A controlled trail of plasmapheresis therapy in severe lupus nephritis. N Engl J Med, 1992,326:1373 - 1379
